249 related articles for article (PubMed ID: 22042564)
21. Predictors of remission of type 2 diabetes mellitus in obese patients after gastrointestinal surgery.
Lee YC; Lee WJ; Liew PL
Obes Res Clin Pract; 2013 Dec; 7(6):e494-500. PubMed ID: 24308892
[TBL] [Abstract][Full Text] [Related]
22. Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study.
Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Lam CLK; Wong CKH
Diabetes Metab Res Rev; 2020 Mar; 36(3):e3236. PubMed ID: 31912598
[TBL] [Abstract][Full Text] [Related]
23. Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.
Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Briatore L; Andraghetti G; Catalano M; Cordera R
Obes Surg; 2014 Jul; 24(7):1036-43. PubMed ID: 24647849
[TBL] [Abstract][Full Text] [Related]
24. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
[TBL] [Abstract][Full Text] [Related]
25. Seven Years of Mini-Gastric Bypass in Type II Diabetes Patients with a Body Mass Index <35 kg/m(2).
Kular KS; Manchanda N; Cheema GK
Obes Surg; 2016 Jul; 26(7):1457-62. PubMed ID: 26475028
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).
Yang J; Wang C; Cao G; Yang W; Yu S; Zhai H; Pan Y
BMC Surg; 2015 Jul; 15():88. PubMed ID: 26198306
[TBL] [Abstract][Full Text] [Related]
27. Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes.
Aminian A; Brethauer SA; Andalib A; Punchai S; Mackey J; Rodriguez J; Rogula T; Kroh M; Schauer PR
Ann Surg; 2016 Oct; 264(4):674-81. PubMed ID: 27433906
[TBL] [Abstract][Full Text] [Related]
28. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?
Milone M; Di Minno MN; Leongito M; Maietta P; Bianco P; Taffuri C; Gaudioso D; Lupoli R; Savastano S; Milone F; Musella M
World J Gastroenterol; 2013 Oct; 19(39):6590-7. PubMed ID: 24151386
[TBL] [Abstract][Full Text] [Related]
29. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.
Hamza N; Abbas MH; Darwish A; Shafeek Z; New J; Ammori BJ
Surg Obes Relat Dis; 2011; 7(6):691-6. PubMed ID: 20688578
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes in gastric bypass patients with and without type 2 diabetes--Waitemata District Health Board experience.
Lam AH; Kim DD; Cutfield R; Walker C; Booth M
N Z Med J; 2013 Nov; 126(1386):21-30. PubMed ID: 24316990
[TBL] [Abstract][Full Text] [Related]
31. [Interpretation of the International Joint Statement on Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes].
Zhang P; Zheng C
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):372-377. PubMed ID: 28440515
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.
Blackstone R; Bunt JC; Cortés MC; Sugerman HJ
Surg Obes Relat Dis; 2012; 8(5):548-55. PubMed ID: 22721581
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.
Musella M; Apers J; Rheinwalt K; Ribeiro R; Manno E; Greco F; Čierny M; Milone M; Di Stefano C; Guler S; Van Lessen IM; Guerra A; Maglio MN; Bonfanti R; Novotna R; Coretti G; Piazza L
Obes Surg; 2016 May; 26(5):933-40. PubMed ID: 26341086
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.
Lee WJ; Chong K; Lin YH; Wei JH; Chen SC
Obes Surg; 2014 Sep; 24(9):1552-62. PubMed ID: 24965545
[TBL] [Abstract][Full Text] [Related]
35. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
36. Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.
Rodrigues MR; Santo MA; Favero GM; Vieira EC; Artoni RF; Nogaroto V; de Moura EG; Lisboa P; Milleo FQ
World J Gastroenterol; 2015 Jun; 21(22):6990-8. PubMed ID: 26078577
[TBL] [Abstract][Full Text] [Related]
37. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.
Brethauer SA; Aminian A; Romero-Talamás H; Batayyah E; Mackey J; Kennedy L; Kashyap SR; Kirwan JP; Rogula T; Kroh M; Chand B; Schauer PR
Ann Surg; 2013 Oct; 258(4):628-36; discussion 636-7. PubMed ID: 24018646
[TBL] [Abstract][Full Text] [Related]
38. Surgery for weight loss in adults.
Colquitt JL; Pickett K; Loveman E; Frampton GK
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
[TBL] [Abstract][Full Text] [Related]
39. From diabetes remedy to diabetes remission; could single-anastomosis gastric bypass be a safe bridge to reach target in non-obese patients?
Osman Abouzeid TA; Ain Shoka AA; Abd Elsamee Atia KS
Asian J Surg; 2019 Jan; 42(1):307-313. PubMed ID: 29866394
[TBL] [Abstract][Full Text] [Related]
40. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study.
Moradi M; Kabir A; Khalili D; Lakeh MM; Dodaran MS; Pazouki A; Kermansaravi M; Alibeigi P; Moazenzadeh H; Abdolhosseini MR; Eghbali F; Baradaran HR
BMC Endocr Disord; 2022 Oct; 22(1):260. PubMed ID: 36289529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
